Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with one of the following lung or chest cancers — non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), oesophageal squamous cell cancer (ESCC), pancreatic neuroendocrine tumour (PNET), or thymic epithelial tumour (TET) — confirmed through a tissue or cell sample.
- People who have been seen at the Clinical Center without a final diagnosis yet, but where doctors strongly suspect one of the above cancer types while waiting for further tissue samples or test results to be reviewed.
- People aged 18 years or older (this trial does not include children, as these cancer types are very rare in younger people).
- People who are able to understand the study and are willing to sign a written consent form agreeing to take part.
Who may not be able to join:
- People who have an active, symptomatic serious organ condition that could make a biopsy (tissue sample procedure) more risky — such as heart disease, a recent heart attack, heart failure, or significant breathing problems.
- People who have other active medical or mental health conditions that the lead study doctor believes could increase the risk of participating.
- People who are HIV-positive and are not currently receiving combination antiretroviral therapy (a standard HIV treatment regimen).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Arun Rajan, M.D., National Cancer Institute (NCI)
Phone: (240) 858-3157
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Allow sample acquisition for use in the study of thoracic malignancies except mesothelioma.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.